Lupin has entered into a definitive agreement to sell its entire stake in Japanese subsidiary Kyowa Pharmaceutical Industry Co. to Plutus Ltd for an enterprise value of 57.36 billion yen, or ₹3,702 crore. The deal helps Lupin to use its capital on markets where it can get better returns.
Lupin to sell Japanese biz for enterprise value of ₹3,702 cr
Date posted: Wednesday 13 November 2019